AKT1 and non-small cell lung carcinoma: The comprehensive pathway included small lung cancer (hsa05222), NSCLC (hsa05223), the PI3K/Akt signaling pathway (hsa04151), and the MAPK signaling pathway (hsa04010) (Fig. 9, Additional Fig. 2).